– New analyses of efficacy endpoints from the Phase 2 VIBRANT trial of verekitug in CRSwNP to be presented during the late-breaking poster session – WALTHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today […]
Category Archives: Pr Newswire
Pr Newswire
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
26
Feb
Feb
Completed enrollment of Cohort C in the Phase 1 ALLOHA™ trial; patients to be treated with commercial-ready manufacturing process Received FDA clearance of INDs for TSC-102-A01 and TSC-102-A03 targeting CD45, for patients with HLA types A*01:01 and A*03:01 Plans to initiate Phase 1 study of both TSC-102 candidates in the second half of 2026 WALTHAM, Mass., Feb. […]
26
Feb
Feb
—Full year 2025 ORLADEYO® net revenue of $601.8 million (+38% y-o-y; +43% y-o-y excluding European ORLADEYO revenue following the sale of the European ORLADEYO business to Neopharmed Gentili S.p.A. on October 1, 2025)— —Record GAAP and non-GAAP operating profit for full year 2025— —Maintained full year 2026 ORLADEYO revenue guidance between $625 and $645 million— […]
Pr Newswire
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
26
Feb
Feb
PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic disease Carmel Nanthakumar, PhD, joins as VP, Translational Biology, following recent appointments of Paul Russell as Chief Development Officer and Catherine McClinton as Head of Clinical Operations Ramsey, Isle of Man, 26 […]
SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ — Higgsfield announces Cinema Studio 2.0, a major evolution of its flagship video tool and the go-to platform for creators and the world’s top ad and film studios. This update redefines directorial control, giving creators the power to produce professional scenes up to 16 times more efficiently. With over […]
DUBAI, UAE, Feb. 26, 2026 /PRNewswire/ — Robo.ai Inc. (NASDAQ: AIIO), a technology company developing a global artificial intelligence machine economy platform, today announced that following the execution of data collection services related agreement with DaBoss.AI Inc. (“DaBoss”) earlier this month, the parties have successfully completed the initial collection and delivery of intelligent data in […]
GUANGZHOU, China, Feb. 26, 2026 /PRNewswire/ — As global demand continues to evolve across residential, commercial, and infrastructure sectors, the Canton Fair’s March Industry Thematic Event turns its focus to Building & Furniture, spotlighting products and solutions that reflect changing expectations for living environments and construction standards. Hosted on the Canton Fair’s always-on digital platform, […]
Industry veteran in global operations and partnerships to spearhead international expansion Operational transformation underway to elevate the brand’s standing in derma beauty SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — MDP+, majority-owned by Morgan Stanley Private Equity Asia, has announced the appointment of Jason Wi as its new Chief Executive Officer. Under Wi’s leadership, the […]
The Company prioritizes local entrepreneurs, community building, and long-term investment to continuously create value for Malaysian society and its economy. KUALA LUMPUR, Malaysia, Feb. 26, 2026 /PRNewswire/ — Mixue Malaysia is continuing to strengthen its presence in the local market through a long-term, community-centric strategy. By prioritizing local entrepreneurship, localized operations, and ongoing investment, Mixue Malaysia continues […]
26
Feb
Feb
Study findings do not support routine use of tecovirimat in people with mpox CHAPEL HILL, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of “Tecovirimat for the Treatment of Mpox (STOMP)” in the New England Journal of Medicine (NEJM). The […]